Design of an international investigator-initiated study on MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A (MOTIVATE)

BACKGROUND: Inhibitor development is the most serious treatment-related complication of replacement coagulation factor VIII (FVIII) therapy for patients with haemophilia A. Immune tolerance induction (ITI), which involves intensive and prolonged treatment with plasma-derived or recombinant FVIII, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Escuriola Ettingshausen, Carmen, Sidonio, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474305/
https://www.ncbi.nlm.nih.gov/pubmed/34589194
http://dx.doi.org/10.1177/20406207211032452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474305/
https://www.ncbi.nlm.nih.gov/pubmed/34589194
http://dx.doi.org/10.1177/20406207211032452

Ejemplares similares